RecruitingNot ApplicableNCT06805942

Embolization for the Treatment of Heel Pain Secondary to Plantar Fasciitis

Sponsor

IR Centers

Enrollment

10 participants

Start Date

Feb 15, 2025

Study Type

INTERVENTIONAL

Conditions

Plantar Fasciitis of Both Feet

Summary

This study evaluates the feasibility and safety of using Lipiodol (ethiodized oil) as an investigational embolic agent for treating pain caused by plantar fasciitis. Participants will undergo a minimally invasive procedure called plantar fascia embolization (PFE) to reduce inflammation and pain in the affected area. The study aims to assess changes in pain levels, foot function, and any potential side effects over a six-month follow-up period.

Eligibility

Min Age: 22 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Lipiodol (ethiodized oil) injection for people with plantar fasciitis of both feet. The study is currently recruiting participants at 1 location. People eligible for this study include aged 22 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICELipiodol (ethiodized oil) injection

Lipiodol will be used as an embolic agent for arterial embolization targeting neovascularity in the plantar fascia to reduce inflammation and pain.

Locations(1)

IR Centers

Falls Church, Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06805942

Related Trials

Temporal Differences in Pain, Muscle Stiffness, and Function in Subjects With Plantar Fasciitis After Myofascial Release Therapy

NCT067549821 location